Page 1996 · Підтримання нормотермії для профілактики інфекції рани — perioperative core temperature control as an evidence-based bundle element for surgical site infection (SSI) prevention.
General and neuraxial anesthesia both blunt the hypothalamic thermoregulatory set point, widening the temperature range the body tolerates before it fights back with vasoconstriction or shivering. Combine that with a cool operating room (kept low for staff comfort and to slow bacterial growth), exposed skin, open body cavities, and room-temperature prep and irrigation fluids, and heat loss routinely outpaces heat production — core temperature commonly falls 1–2°C within the first hour unless actively prevented.
In the awake state, the hypothalamus defends core temperature within an extremely tight interthreshold range (~0.2°C) using vasoconstriction, non-shivering thermogenesis, and shivering. General anesthetics (volatile agents, propofol, opioids) and neuraxial blocks (spinal, epidural) both widen this range roughly twenty-fold, to nearly 4°C, and lower the vasoconstriction threshold below normal core temperature.
The result: for the first 30–60 minutes after induction, warm blood that was previously vasoconstricted to the core redistributes to cooler peripheral tissue. This "redistribution hypothermia" — a passive equilibration, not true heat loss to the environment — accounts for the majority of the temperature drop seen in the first hour of any case, and it happens even in a warm room.
Neuraxial anesthesia compounds the problem: it blocks sympathetic vasoconstrictor tone below the block level, so the lower body cannot vasoconstrict to defend temperature at all, and patients often underestimate their own cold sensation because afferent thermal sensation is blunted too.
Redistribution — not environmental loss — explains most of the temperature drop in the first hour after induction. This is why pre-warming the patient's periphery before anesthesia begins is one of the single most effective, and most underused, interventions.
Once redistribution has run its course, ongoing heat loss to the environment continues through four physical mechanisms:
• Radiation (~40% of ongoing loss): exposed skin radiates infrared heat to the cooler surfaces of the room • Convection: air currents from laminar-flow ventilation systems strip a thin warm boundary layer from exposed skin • Evaporation: skin antiseptic solutions, open body cavities, and exposed viscera lose heat rapidly as moisture evaporates • Conduction: contact with a cold OR table, unwarmed positioning gel pads, and room-temperature irrigation or prep fluids
Large incisions, laparotomies, and prolonged exposure of open cavities dramatically amplify evaporative and radiative losses — a large open abdominal case can lose heat several times faster than a small, draped extremity procedure.
Some patients and cases are inherently higher risk for hypothermia:
• Age extremes: neonates and infants have a high surface-area-to-mass ratio; older adults have reduced basal metabolic rate and thinner subcutaneous fat • Low body mass index: less insulating subcutaneous fat • Higher ASA physical status and comorbidity burden: reduced physiologic reserve to generate compensatory heat • Combined general plus regional/neuraxial anesthesia: loses two independent thermoregulatory defenses at once • Procedure duration: longer cases give more time for the core temperature to fall toward a lower plateau before warming interventions can compensate
Without intervention, temperature does not simply keep falling indefinitely — it drifts toward a lower steady-state plateau as heat loss and reduced heat production reach a new equilibrium, typically around 34–35°C in an unwarmed multi-hour case.
Mild perioperative hypothermia — just 1–2°C below normal — is not a benign vital-sign deviation. It triggers thermoregulatory vasoconstriction that shunts blood away from subcutaneous and wound tissue, cutting local oxygen tension, and it directly impairs neutrophil oxidative killing. Both mechanisms compound to meaningfully raise the risk of surgical site infection.
Even mild hypothermia triggers a thermoregulatory vasoconstriction reflex aimed at preserving core temperature by sacrificing peripheral, including subcutaneous, perfusion. Because the wound bed sits in that sacrificed peripheral compartment, blood flow — and with it, delivered oxygen — falls precisely where it is needed most for host defense and repair.
Oxygen delivery is the rate-limiting step for neutrophil bactericidal function: the oxidative (respiratory) burst that neutrophils use to kill phagocytosed bacteria depends on molecular oxygen as the substrate for NADPH oxidase, which generates the superoxide and downstream reactive oxygen species that destroy engulfed pathogens. A cold, vasoconstricted wound bed simply cannot supply enough oxygen to sustain this killing mechanism at full capacity.
In the landmark Kurz et al. (NEJM, 1996) colorectal surgery trial, patients kept mildly hypothermic (mean 34.7°C) had an SSI rate of 19%, versus 6% in patients actively warmed to normothermia (mean 36.6°C) — a threefold difference — and the normothermic group was also discharged roughly 2.6 days sooner.
Beyond oxygen delivery, hypothermia directly slows the neutrophil itself:
• Oxidative (respiratory) burst: enzyme kinetics of NADPH oxidase and downstream reactive-oxygen production slow measurably per degree below 37°C • Chemotaxis: the speed and directional accuracy with which neutrophils migrate toward a chemotactic gradient at the wound site decreases in cold tissue • Phagocytosis: engulfment efficiency of opsonized bacteria is reduced • Opsonization: antibody- and complement-mediated tagging of bacteria for destruction is itself temperature-sensitive, adding a second layer of impairment on top of the neutrophil's own slowed response
Together, a cold wound bed presents fewer functional immune effector cells, delivering less oxygen, to a bacterial inoculum that is otherwise unaffected by the patient's temperature — a mismatch strongly favoring the pathogen.
Hypothermia's physiologic reach extends well past SSI risk, which is part of why it is treated as a vital-sign target rather than a minor comfort issue:
• Coagulation: cold measurably impairs platelet function and slows the enzymatic reactions of the coagulation cascade, increasing intraoperative blood loss and transfusion requirements — and transfusion itself is an independent risk factor for infection • Cardiac morbidity: hypothermia increases myocardial oxygen demand through shivering and catecholamine surges, raising the risk of perioperative cardiac events in vulnerable patients • Drug metabolism: reduced core temperature slows hepatic metabolism of anesthetic agents and neuromuscular blockers, prolonging emergence and recovery time
These compounding effects are why perioperative normothermia is treated as a foundational vital sign to defend, not merely a nice-to-have comfort measure.
Passive insulation — a cotton blanket — cannot prevent redistribution hypothermia and barely slows environmental heat loss. Active warming, using forced-air convective blankets, fluid warmers for intravenous crystalloids and blood products, and warmed irrigation solutions, is now standard of care for any case expected to exceed 30–60 minutes, and is recommended explicitly by WHO, NICE, and surgical-care-improvement bundles.
A forced-air warming system pairs a blower unit with an inflatable blanket draped over the patient's exposed skin. Warm air (typically ~40–43°C) circulates through the blanket and across the skin surface, delivering convective heat that directly counteracts the radiative and convective losses described in Stage 1.
Critically, applying this system before induction — "pre-warming" the peripheral tissue for at least 30 minutes — raises peripheral temperature and narrows the core-to-peripheral gradient that drives redistribution hypothermia. Because redistribution accounts for most of the first-hour drop, pre-warming is disproportionately effective per minute of effort compared with warming started only after the case is underway.
Pre-warming the skin surface for 30 minutes before induction can cut the first-hour redistribution-related temperature drop roughly in half, because it reduces the core-to-peripheral temperature gradient that drives the redistribution itself, rather than only compensating for losses after they occur.
Intravenous fluid warmers — dry-heat cartridge devices or countercurrent water-bath systems — bring crystalloids, colloids, and blood products to near-body temperature immediately before they enter the patient. Every liter of unwarmed room-temperature crystalloid infused can drop core temperature by roughly a quarter of a degree; in cases requiring large-volume resuscitation, this can single-handedly offset all of the gains from a forced-air blanket if left unaddressed.
Similarly, irrigation fluid used to flush open cavities or joints during long laparoscopic, open abdominal, or orthopedic procedures should be warmed — cold irrigation fluid poured directly into a body cavity is an efficient, direct route for conductive heat loss that bypasses the skin entirely.
No single intervention reliably maintains normothermia on its own in a longer case. The most effective strategy combines forced-air warming, IV and irrigation fluid warming, a modestly increased ambient OR temperature during induction and vulnerable periods, and minimizing unnecessary skin exposure — a comprehensive, multimodal bundle rather than any single measure in isolation.
This is the clinical rationale behind treating "active warming measures" as a graded variable in practice — from none, to a single measure such as a forced-air blanket alone, to a comprehensive combination of forced-air plus fluid warming. Comprehensive strategies consistently outperform partial ones at holding core temperature above the 36°C target throughout a case.
Guidelines from the WHO Surgical Safety Checklist, NICE clinical guideline CG65, and perioperative nursing societies recommend continuous core temperature monitoring for any procedure under general or neuraxial anesthesia expected to last beyond 30 minutes, with an explicit, unambiguous target: maintain core temperature at or above 36°C throughout the preoperative, intraoperative, and immediate postoperative periods.
Not every thermometer site reflects true core temperature under anesthesia. Reliable core-reflective monitoring sites include:
• Distal esophageal probe: positioned near the heart, considered one of the most accurate and widely used intraoperative sites • Bladder catheter thermistor: convenient in cases already requiring urinary catheterization, accurate when urine flow is adequate • Nasopharyngeal probe: reflects brain temperature closely, useful in head and neck procedures • Pulmonary artery catheter: the historical gold standard, but far too invasive for routine use outside cardiac or critical-care settings
Skin, axillary, and oral measurements are considered unreliable during general anesthesia because peripheral vasoconstriction and environmental exposure decouple them from true core temperature — they should not be relied upon as the sole intraoperative monitor.
The clinical target is not merely "avoid overt hypothermia" — it is a specific, documented number: core temperature ≥36°C, measured continuously where feasible, or at minimum every 15–30 minutes when continuous monitoring is not available. When a reading trends toward or below 36°C, the anesthesia team escalates warming intensity immediately — adding a fluid warmer, increasing the forced-air blanket setting, or raising ambient OR temperature — rather than waiting for temperature to fall further before reacting.
Surgical Care Improvement Project (SCIP-Inf-10) and Joint Commission quality measures require normothermia to be documented within the 30 minutes immediately before or after anesthesia end for major surgery — turning perioperative temperature control into a publicly reported hospital quality metric, not just a bedside preference.
The logic modeled in this simulator mirrors the real clinical decision rule: a continuous temperature readout is compared against the 36°C threshold in real time, and that comparison — together with how much active warming is already deployed — drives the recommendation to either continue the current approach or escalate warming measures immediately, closing the loop between monitoring and intervention rather than treating them as separate steps.
The mechanistic story of vasoconstriction, reduced tissue oxygenation, and impaired neutrophil function is backed by clinical trial evidence: randomized studies and subsequent meta-analyses consistently show that actively maintaining normothermia reduces SSI incidence, intraoperative blood loss, transfusion requirements, and length of hospital stay — making perioperative warming one of the highest-value, lowest-cost elements of any surgical care improvement bundle.
Kurz et al. (New England Journal of Medicine, 1996) randomized roughly 200 colorectal surgery patients to routine intraoperative care versus active warming to maintain normothermia. The hypothermic group (mean 34.7°C) had an SSI rate of 19%, compared with 6% in the actively warmed, normothermic group (mean 36.6°C) — a threefold reduction — alongside a shorter hospital stay of about 2.6 days.
Melling et al. (Lancet, 2001) extended the finding to clean surgery (breast, varicose vein, and hernia repair) in 421 patients, showing that even simple local or systemic warming before and during surgery cut wound infection rates by more than half, from roughly 14% to 5%, demonstrating the effect generalizes beyond major abdominal surgery.
A subsequent Cochrane systematic review pooling multiple randomized trials found that active warming to maintain perioperative normothermia reduced the relative risk of surgical site infection by roughly 60–70% compared with standard, unwarmed care — one of the largest effect sizes of any single perioperative intervention studied for SSI prevention.
The consistency of the effect across colorectal, orthopedic, breast, hernia, and vascular surgery cohorts is explained by the same shared mechanism established in Stage 2: normothermia preserves subcutaneous tissue oxygen tension and neutrophil oxidative killing capacity regardless of the specific surgical field. Because the benefit does not depend on the type of operation, normothermia maintenance generalizes as a universal component of surgical care rather than a procedure-specific intervention.
Improved coagulation under normothermic conditions also reduces blood loss and transfusion requirements, and transfusion itself carries an independent, well-documented association with increased postoperative infection risk — meaning normothermia lowers SSI risk through at least two converging pathways, not one.
Reflecting this weight of evidence, normothermia maintenance now appears as a required or strongly recommended element in essentially every major perioperative quality framework: the WHO Surgical Safety Checklist, the Surgical Care Improvement Project (SCIP), and Enhanced Recovery After Surgery (ERAS) protocols all list active temperature management alongside antibiotic prophylaxis timing, glycemic control, and appropriate hair-removal technique as core, low-cost, high-yield components of infection prevention.
Unlike many perioperative interventions, the cost of active warming — a forced-air blanket and a fluid warmer — is modest relative to the downstream cost of treating a surgical site infection, which routinely requires reoperation, extended antibiotic courses, and additional hospital days. This favorable cost-benefit ratio is a major reason normothermia maintenance has become a default standard rather than an optional add-on.